BlackRock Updates ZBH Stake in SC 13G/A Filing
Ticker: ZBH · Form: SC 13G/A · Filed: Jan 25, 2024 · CIK: 1136869
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investing
TL;DR
**BlackRock just updated its ZBH ownership, signaling its current position in the stock.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 25, 2024, indicating its ownership of ZIMMER BIOMET HOLDINGS, INC. (ZBH) common stock as of December 31, 2023. This filing, Amendment No. 9, updates their previous disclosures regarding their stake in the orthopedic and surgical appliance company. This matters to investors because BlackRock is a major institutional investor, and changes in their reported holdings can signal their confidence (or lack thereof) in the company's future prospects, potentially influencing other investors.
Why It Matters
Large institutional investors like BlackRock can influence stock prices through their buying and selling activity, and their reported holdings offer a glimpse into their investment strategies.
Risk Assessment
Risk Level: low — This is a routine disclosure filing by a large institutional investor and does not inherently indicate significant new risks or opportunities.
Analyst Insight
Investors should note that BlackRock, a major institutional player, continues to hold a position in ZBH. While this filing doesn't reveal specific changes in share count, it confirms their ongoing interest. Smart investors might monitor future BlackRock filings for significant shifts in ownership that could signal a change in their investment thesis for ZBH.
Key Numbers
- 98956P102 — CUSIP Number (identifies the Common Stock of ZIMMER BIOMET HOLDINGS, INC.)
- 0001364742 — BlackRock Inc. CIK (Central Index Key for the filing entity)
- 0001136869 — ZIMMER BIOMET HOLDINGS, INC. CIK (Central Index Key for the subject company)
Key Players & Entities
- BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
- ZIMMER BIOMET HOLDINGS, INC. (company) — the subject company whose common stock is being reported
- December 31, 2023 (date) — the date of the event which required the filing
- January 25, 2024 (date) — the filing date of the SC 13G/A
- Amendment No. 9 (number) — the specific amendment number of this filing
Forward-Looking Statements
- BlackRock will continue to be a significant institutional holder of ZIMMER BIOMET HOLDINGS, INC. common stock. (BlackRock Inc.) — high confidence, target: Q2 2024
- Future SC 13G/A filings from BlackRock regarding ZBH will likely be routine updates unless there's a major change in their ownership percentage. (BlackRock Inc.) — high confidence, target: Q4 2024
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G, as stated in the 'FORM TYPE: SC 13G/A' and 'SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 9)' sections.
Who is the filer of this SC 13G/A?
The filer of this SC 13G/A is BlackRock Inc., as indicated under the 'FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc.' section.
What company's securities are the subject of this filing?
The securities of ZIMMER BIOMET HOLDINGS, INC. are the subject of this filing, as stated under 'SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ZIMMER BIOMET HOLDINGS, INC.' and 'ZIMMER BIOMET HOLDINGS INC (Name of Issuer)'.
What was the date of the event that required this filing?
The date of the event which required the filing of this statement was December 31, 2023, as specified under '(Date of Event Which Requires Filing of this Statement) December 31, 2023'.
Under which rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13d-1(b), as indicated by the '[X] Rule 13d-1(b)' checkbox selection.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 25, 2024 regarding ZIMMER BIOMET HOLDINGS, INC. (ZBH).